ArticleClinical medicine (London, England)2026
Metabolic dysfunction-associated steatotic liver disease (MASLD) is under-recognised: Should hepatic elastography be integrated into early risk stratification for people with type 2 diabetes?
Aftab Ala et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.